$70.35
-2.3%Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Chief Commercial Officer
Compensation
$751,653
Chief Executive Officer, President & Director
Compensation
$1,134,263
Chief Financial Officer
Compensation
$817,591
Chief Legal Officer & Secretary
Chief Medical Officer
Compensation
$838,050
Chief Opearating Officer
Compensation
$764,950
Chief Technical Officer
Executive Chairman
Compensation
$164,000
Founder & Chair of Scientific Advisory Board
Compensation
$88,542
Senior Vice President & Head of Chemistry
During the last 12 months, insiders have sold $73.24M worth of IRON shares, with no buying activity reported.
0
0.00
3.5K
233.47K
-233K
-$233K
0
0.00
60.9K
4.42M
-4.4M
-$4.42M
0
0.00
776.5K
62.34M
-62.3M
-$62.34M
0
0.00
104.0K
6.24M
-6.2M
-$6.24M
No buying activity
Ai Dmi Llc
10 Percent Owner
$59.87M
Bitterman Kevin
Director
$8.59M
Quisel John D
Director, Officer: Chief Executive Officer
$1.54M
Yu Jonathan Yen-Wen
Officer: Chief Operating Officer
$894K
Savage William Jacob
Officer: Chief Medical Officer
$876K
Strong bearish signal with $73.24M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
IRON - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | June 18, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 24, 2025 | June 11, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | May 01, 2024 | June 12, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 20, 2023 | June 09, 2023 | 2023 | |
DEF 14A DEF 14A 2021 N/A | August 17, 2021 | September 29, 2021 | 2021 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.